Up Next
Back to Show
Amanpour & Co.
Jennifer Doudna on FDA Approval of First CRISPR Treatments
More than a decade ago, pioneering biochemist Jennifer Doudna co-invented CRISPR, the gene editing technology which earned her the Nobel Prize in chemistry. Now, the very first treatment based on CRISPR has been approved in the U.K. and the U.S., a landmark decision for the treatment of sickle cell disease and for the potential of this rapidly advancing field. Dr. Doudna joins to discuss.
Support Provided By
Season
Unlock with PBS Passport
55:18
Alberto Gonzales; Idit Ohel; Justin Levitt
Unlock with PBS Passport
55:47
Thierry Arnaud; Nathalie Tocci; Dr. Sania Nishtar; Tina Fordham; Edward Fishman
Unlock with PBS Passport
55:47
Colum McCann; Graydon Carter
Unlock with PBS Passport
55:47
Vincent Warren; Michael Lewis; W. Kamau Bell; Jessica Chen Weiss
Unlock with PBS Passport
55:47
Chuck Hagel; Antonio Costa; Jason Stanley
Unlock with PBS Passport
55:47
Baiba Braže; Makena Kelly; Shaima Al-Obaidi; Clay Risen
Unlock with PBS Passport
55:47
Dara Massicot; Özgür Özel; Olivia Hill; Asako Gladsjo and Dr. Le’Shauna Phinazee
Unlock with PBS Passport
55:16
David Miliband; Omar El Akkad; Carrie Besnette Hauser
Unlock with PBS Passport
55:24
Maja Stojanovic; Stephen Graham; Nicholas Kristof
Unlock with PBS Passport
55:46
Celeste A. Wallander; Greg Swenson; John Green
Unlock with PBS Passport
55:29
Jeremy Diamond; Olga Cherevko; Oleksiy Goncharenko; Simon Harris; Derek Thompson and Ezra Klein
Unlock with PBS Passport
55:47
Gavin Kelleher; Elizabeth Goitein; Noubar Afeyan; Mary McCord